Social Sentiment for ACHN
Bullish vs. Bearish opinions
Weighted Sentiment -0.73
Achillion Pharmaceuticals Forecast and Stock Analysis
Technical ACHN stock analysis for Thursday May 23, 2019.
|Price to book||USD 1.56|
|Next Earnings Date||2019-08-07|
Achillion Pharmaceuticals gained 0.36% in the last trading day ( Thursday, 23rd May 2019 ), rising from $2.80 to $2.81 During day the stock fluctuated 3.66% from a day low at $2.73 to a day high of $2.83. The price has risen in 5 of the last 10 days , but is still down by -1.06% for this period. Volume fell in the last day by -499 536 shares, and in total, 586 100 shares bought and sold for approximately $1.65 million. You should take into consideration that a falling volume on higher prices causes divergence and may be an early warning about possible changes for the next couple of days.
- 30 day high of the ACHN stock price was $3.25 and low was $2.67.
- 90 day high was $3.48 and low was $2.36.
- 52 week high for the Achillion Pharmaceuticals - $3.98 and low - $1.29.
Achillion Pharmaceuticals lies in the lower part of a very wide and weak rising trend in the short term, and this will normally pose a very good buying opportunity. A break down the bottom trend line at $2.70 will firstly indicate a slower raising rate, but may also be a early warning for a trend shift. Given the current short-term trend, the stock is expected to rise 6.27% during the next 3 months and, with 90% probability hold a price between $2.87 and $3.66 at the end of this period.
A buy signal was issued from a pivot bottom point on Wednesday May 22, 2019, which indicates further gains until a new top pivot has been found. Volume fell during the last trading day despite gaining prices. This causes a divergence between volume and price and may be an early warning. The stock should be watched closely. Some negative signals were issued as well, and these may have some influence on the near short-term development. Achillion Pharmaceuticals holds sales signals from both short- and long-term moving averages. In addition, there is a general sales signal from the relation between the two signals where the long-term average is above the short-term average. On corrections up there will be some resistance from the lines at $2.94 and $3.02. A break-up above any of these levels will issue buy signals.
Relative Strength Index (RSI)
RSI14 is 43 and the stock is currently not being overbought or oversold
Support & Resistance
Achillion Pharmaceuticals finds support from accumulated volume at $2.67.
This stock may move much during a day (volatility) and with a large prediction interval from the Bollinger Band this stock is considered to be "high risk". During the last day, the stock moved $0.10 between high and low, or 3.66%. For the last week, the stock has had a daily average volatility of 7.03%.
Our recommended stoploss: We hold a sell evaluation for this stock. No stop-loss set.
7.03 %Average volatility
Very Low Low Medium High Very High
The Achillion Pharmaceuticals stock holds several negative signals and despite the positive trend we believe Achillion Pharmaceuticals will perform weak in the next couple of days or weeks. Therefore, we hold a negative evaluation of this stock.
|Golden Star Signal|
Get competitive edge
The signal uses moving averages and adds special requirements that convert the very good Golden Cross into a Golden Star.
This signal is rare and, in most cases, gives a very good return. From 8.000 stocks usually only a few will trigger a Golden Star Signal per day!
Get access to Golden Star list now
|ACHN $2.81 ($0.01 0.36%)|
ACHN is up $0.01 today, but where's it headed in 2019?
|Zacks Investment Research is releasing its prediction for ACHN based on the 1-3 month system that more than doubles the S&P 500.
This report is free today for StockInvest.us readers.
Click here – the ACHN analysis is free »
From Our Blog
- Trading With Moving Average
- Pivot Points
- Accumulated Volume - Support and Resistance
- Volume - The Indicator You Really Need to Know
- We Give Back!
- Better Buy: Amazon vs. Facebook
- Better Buy: Apple vs. Microsoft
- Relative Strength Index (RSI)
- How to Lose Money When Trading: Part 2
- How to Lose Money When Trading: A Trader is Born
- Our 2017 Christmas Donation
- The Golden Star
- Announcing Partnership With CityFALCON
- Why correct moving average matters
- NASDAQ down -4.17%. Our portfolio is up +8.56%
- New Feature Added: Golden Star Signal
- Pick a Winner With StockInvest.us